Cybin (HELP) Interest & Investment Income (2020 - 2026)
Cybin's (HELP) quarterly Interest & Investment Income came in at $1.6 million in Q1 2026, down 72.66% YoY from $5.8 million in Q1 2025, and up 5.06% on a QoQ basis from $1.5 million in Q4 2025.
Cybin (HELP) Interest & Investment Income (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Interest & Investment Income data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Interest & Investment Income fell 72.66% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 44.54% YoY) and the FY2026 annual result came in at $5.1 million, down 14.86% from the prior year.
- Interest & Investment Income advanced to $1.6 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.8 million in Q1 2025 to a low of -$101603.6 in Q1 2023.
- A 5-year average of $865814.5 and a median of $62534.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 99.57% — and 2024, when it surged 5816074.18%.
- Tracing HELP's Interest & Investment Income over 5 years: stood at $157.0 in 2022, then slumped by 34.03% to $103.57 in 2023, then jumped by 1124748.43% to $1.2 million in 2024, then rose by 28.93% to $1.5 million in 2025, then climbed by 5.06% to $1.6 million in 2026.
- The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2,141.00 |
| Mar 31, 2024 | 459,162.51 |
| Dec 31, 2023 | 103.57 |
| Sep 30, 2023 | 38.79 |
| Jun 30, 2023 | 62,534.01 |
| Feb 28, 2023 | -101,603.62 |
| Dec 31, 2022 | 157.00 |
| Sep 30, 2022 | 174.00 |
| May 31, 2022 | 3,087.59 |
| Mar 31, 2022 | 83.00 |
| Dec 31, 2021 | 63.00 |
| Sep 30, 2021 | 40,514.87 |
| Jun 30, 2021 | 35.80 |